NCT00487604

Brief Summary

The purpose of this study is to determine whether the use of drug eluting stents is associated with higher rates of death, myocardial infarction, and major bleeding. In addition, the overall economic costs of implanting drug eluting stents compared to bare metal stents will be assessed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
9,800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2007

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2007

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 14, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 18, 2007

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2008

Completed
Last Updated

August 2, 2007

Status Verified

April 1, 2007

First QC Date

June 14, 2007

Last Update Submit

August 1, 2007

Conditions

Coronary Artery Disease

Keywords

Coronary Artery DiseaseDrug Eluting StentBare Metal StentSubacute thrombosisBleedingEconomic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Coronary artery stenting between March 1, 2001 and March 30, 2006

You may not qualify if:

  • Implanted investigational drug eluting stents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sacred Heart Medical Center

Spokane, Washington, 99204, United States

RECRUITING

MeSH Terms

Conditions

Coronary Artery DiseaseHemorrhage

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michael E. Ring, MD

    Providence Health & Services

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lynn A. Shuler, RN, MA

CONTACT

509.474.4302lshuler@this.org

Sandra J. Albritton, RN, MSN

CONTACT

509.474.4345salbritt@this.org

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 14, 2007

First Posted

June 18, 2007

Study Start

May 1, 2007

Study Completion

May 1, 2008

Last Updated

August 2, 2007

Record last verified: 2007-04

Locations

US(1)